Zebra Capital Management LLC Harmony Biosciences Holdings, Inc. Transaction History

Zebra Capital Management LLC

  • $20 Million
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$45.4 - $60.91 $200,395 - $268,856
4,414 New
4,414 $243,000
Q4 2021

Feb 14, 2022
SELL
$34.09 - $43.91 $210,437 - $271,056
-6,173 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$25.68 - $38.61 $158,522 - $238,339
6,173 New
6,173 $237,000

Others Institutions Holding HRMY

# of Institutions
243
Shares Held
45.2M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.91B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email